We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
iShares Core Universal USD Bond ETF
IUSB
$43.1B
| $4.55M | 0.02% |
85,412
-9,691
| -10% | -$521K |
|
502
Capital One
COF
$134B
| $4.53M | 0.02% |
27,989
+5,329
| +24% | +$870K |
|
503
Chipotle Mexican Grill
CMG
$41.5B
| $4.52M | 0.02% |
124,250
+2,850
| +2% | +$104K |
|
504
Royal Bank of Canada
RY
$293B
| $4.48M | 0.02% |
45,065
+7,025
| +18% | +$716K |
|
505
Adaptive Biotechnologies
ADPT
$3.97B
| $4.48M | 0.02% |
131,841
+3,727
| +3% | +$135K |
|
506
Dick's Sporting Goods
DKS
$18.7B
| $4.47M | 0.02% |
37,338
+846
| +2% | +$98.4K |
|
507
ING
ING
$102B
| $4.45M | 0.02% |
306,941
+15,819
| +5% | +$211K |
|
508
Snap-on
SNA
$21.5B
| $4.37M | 0.02% |
20,935
-2,905
| -12% | -$644K |
|
509
Brookfield Infrastructure Partners
BIP
$18B
| $4.36M | 0.02% |
116,450
+24,324
| +26% | +$903K |
|
510
Vertex Pharmaceuticals
VRTX
$126B
| $4.33M | 0.02% |
23,873
+6,477
| +37% | +$1.26M |
|
511
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $4.32M | 0.02% |
34,341
+16,224
| +90% | +$2.09M |
|
512
Aon
AON
$76B
| $4.31M | 0.02% |
15,081
+3,081
| +26% | +$828K |
|
513
Bank of Montreal
BMO
$127B
| $4.29M | 0.02% |
42,984
+2,374
| +6% | +$239K |
|
514
Peloton Interactive
PTON
$2.46B
| $4.27M | 0.02% |
49,031
+8,086
| +20% | +$894K |
|
515
iShares Core S&P US Growth ETF
IUSG
$33.7B
| $4.27M | 0.02% |
41,673
+6,716
| +19% | +$709K |
|
516
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.38B
| $4.25M | 0.02% |
109,125
+3,712
| +4% | +$149K |
|
517
WisdomTree International SmallCap Dividend Fund
DLS
$1.08B
| $4.22M | 0.02% |
56,885
+12,679
| +29% | +$965K |
|
518
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
| $4.22M | 0.02% |
32,400
+2,889
| +10% | +$379K |
|
519
Oshkosh
OSK
$9.59B
| $4.21M | 0.02% |
41,156
+2,783
| +7% | +$320K |
|
520
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.61B
| $4.21M | 0.02% |
49,346
+510
| +1% | +$44.6K |
|
521
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $4.2M | 0.02% |
51,265
+12,219
| +31% | +$1M |
|
522
Agilent Technologies
A
$41.2B
| $4.17M | 0.02% |
26,491
+22,263
| +527% | +$3.6M |
|
523
Generac Holdings
GNRC
$12.5B
| $4.17M | 0.02% |
10,195
+1,262
| +14% | +$541K |
|
524
DTE Energy
DTE
$29.1B
| $4.16M | 0.02% |
37,205
+27,260
| +274% | +$3.2M |
|
525
Vanguard FTSE Europe ETF
VGK
$31.4B
| $4.15M | 0.02% |
63,323
+15,987
| +34% | +$1.1M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.